Where does Aurora Spine, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aurora Spine, Inc. ranks #20,788 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aurora Spine, Inc. hold?

Aurora Spine, Inc. holds 13 US utility patents granted between 2016 and 2025, spanning 2 technology areas.

What is Aurora Spine, Inc.'s Innovation Score?

Aurora Spine, Inc. has an Innovation Score of 29.1 out of 100 (29th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aurora Spine, Inc. focus on?

Aurora Spine, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 13 patents, ranking #1,352 of 7,127 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Aurora Spine, Inc.'s patent grant rate increasing or decreasing?

Aurora Spine, Inc.'s recent grant velocity is +75% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Aurora Spine, Inc.'s patents?

Aurora Spine, Inc.'s patents average 6.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aurora Spine, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aurora Spine, Inc.

USPTO PatentsView assignee record - 13 granted patents across 2 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aurora ranks #20,788 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 2 technology areas.

#20,788
of 49,997 US assignees by volume: 29th percentile
by Innovation Score (29.1/100): 6.4
avg claims per patent: +75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20788 · US Corporation #20,788 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,788/49,997
PHOTO-FINISH AstraZeneca…
CPC-NARROW A61B · 2 areas
INNOV-THIN 29.1/100
CLAIMS-SPARSE 6.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AstraZeneca Pharmaceuticals LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aurora’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (31%) Velocity 11.1 pts (38%) Breadth 5.0 pts (17%) Claim depth 3.8 pts (13%)

Qualcomm Incorporated · highest

85
Alastin Skincare · near

29
QBO Coffee · near

29
Aurora Spine · this assignee

29
Documill OY · near

29
Micron Devices · near

29
3D Lighting… · lowest

7

What this shows Aurora's Innovation Score is 29.1/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aurora?

Each dot is one of Aurora’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aurora’s own 6.4 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aurora vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aurora's grants concentrate

Aurora Spine, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2016. By volume, Aurora sits between AstraZeneca Pharmaceuticals LP and Avdel UK Limited.

Aurora's three-year grant acceleration

Aurora Spine, Inc. shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Astrazeneca Pharm…

13
Asymptote

13
Athenex

13
Atlantic Health S…

13
Austin Engineering

13
Autotech Engineer…

13
Ava Labs

13
Avdel UK

13
Aurora Spine ◀

13

What this shows Aurora holds 13 patents at rank #20,789, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aurora

By rank, the assignees closest to #20,789 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Aurora's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aurora, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Aurora ranks #1,352 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Documill OY 29 Micron Devices LLC 29 Alastin Skincare, Inc. 29 QBO Coffee GMBH 29

Aurora's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 29th percentile higher than 29% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Aurora Spine, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	7.7%
2017	1	7.7%
2018	1	7.7%
2019	1	7.7%
2020	2	15.4%
2022	1	7.7%
2023	3	23.1%
2024	1	7.7%
2025partial year	2	15.4%

Which technologies does Aurora Spine, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 13

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 13

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aurora Spine, Inc.'s patent record in context - here's where to go next.

Aurora Spine, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #20,788 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aurora Spine, Inc. against AstraZeneca Pharmaceuticals LP, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.